Avalo Therapeutics (AVTX) Preferred Shares (2017 - 2021)
Avalo Therapeutics posted quarterly Preferred Shares of $1000.0 for Q1 2021, down 20.45% year-on-year from $1257.0 in Q1 2020, and little changed on a QoQ basis from $1000.0 in Q4 2020.
Avalo Therapeutics (AVTX) has 5 years of Preferred Shares data on file, last reported at $1000.0 in Q1 2021.
- For the quarter ending Q1 2021, Preferred Shares fell 20.45% year-over-year to $1000.0; the trailing twelve-month figure through Mar 2021 stood at $1000.0 (down 20.45% YoY), and the FY2020 full-year result was $1000.0, down 65.0% from the prior year.
- Preferred Shares for Q1 2021 stood at $1000.0, roughly flat from $1000.0 in the prior quarter.
- Across five years, Preferred Shares topped out at $2857.0 in Q4 2018 and bottomed at $4.0 in Q1 2017.
- The 5-year median for Preferred Shares is $1257.0 (2020), against an average of $1672.0.
- The widest annual swing landed in 2019, when Preferred Shares changed 0.0%; it then sank 65.0% in 2020.
- A 5-year view of Preferred Shares shows it stood at $4.0 in 2017, then surged by 71325.0% to $2857.0 in 2018, then changed by 0.0% to $2857.0 in 2019, then slumped by 65.0% to $1000.0 in 2020, then changed by 0.0% to $1000.0 in 2021.
- The last three Preferred Shares figures came in at $1000.0 (Q1 2021), $1000.0 (Q4 2020), and $1257.0 (Q3 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | 1,257.00 |
| Jun 30, 2020 | 1,257.00 |
| Mar 31, 2020 | 1,257.00 |
| Dec 31, 2019 | 2,857.00 |
| Sep 30, 2019 | 2,857.00 |
| Jun 30, 2019 | 2,857.00 |
| Mar 31, 2019 | 2,857.00 |
| Dec 31, 2018 | 2,857.00 |
| Jun 30, 2017 | 4.00 |
| Mar 31, 2017 | 4.00 |